Table 1—

Clinical and metabolic characteristics of the FINRISK cohort (n = 3,201) by sex

MenWomenP
n1,5381,663
Age (years)54.2 ± 5.954.5 ± 6.10.257
BMI (kg/m2)27.6 ± 3.827.4 ± 4.90.123
Waist circumference (cm)97.8 ± 10.884.2 ± 11.9<0.001
WHR0.95 ± 0.070.81 ± 0.07<0.001
Systolic blood pressure (mmHg)144 ± 19142 ± 210.098
Diastolic blood pressure (mmHg)88 ± 1184 ± 11<0.001
Total cholesterol (mmol/l)6.02 ± 1.045.98 ± 1.100.251
HDL cholesterol (mmol/l)1.25 ± 0.331.51 ± 0.35<0.001
LDL cholesterol (mmol/l)3.94 ± 0.933.82 ± 0.980.001
Triclycerides (mmol/l)1.96 ± 1.301.45 ± 0.92<0.001
BMI (kg/m2)
    <25.025.235.4<0.001
    25.0–29.949.838.3<0.001
    ≥3025.026.30.445
WHR >0.9 in men and >0.85 in women78.123.6<0.001
Hypertension66.058.1<0.001
Dyslipidemia48.827.0<0.001
  • Data are means ± SD or percent. Hypertension: systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg or use of oral antihypertensive medication. Dyslipidemia: triglycerides ≥1.7 mmol/l or HDL cholesterol <0.9 in men or <1.0 mmol/l in women or use of lipid-lowering medication.